We investigated the presence of EP 1 receptor in the urothelium and its role in micturition reflex by examining the effect of intravesical administration of prostaglandin E 2 (PGE 2 ), an EP 1 agonist (ONO-DI-004), acetic acid, and capsaicin. Age-matched EP 1 -KO mice and C57BL/6 wild-type (WT) mice were used. Western blots and standard immunohistochemical procedures were performed. Cystometrygram (CMG) was performed without anesthesia in a restraining cage. ATP release from the cultured urothelium cells was performed using luciferin-luciferase luminometry. The EP 1 receptor was found to be present in the urothelium. In WT mice, PGE 2 infusion shortened the intercontraction interval (ICI) in a dose-dependent fashion; however, it did not alter the ICI in EP 1 -KO mice. The EP 1 agonist significantly shortened the ICI in WT mice, but not in EP 1 -KO mice. Acetic acid and capsaicin shortened the ICI in both WT mice and EP 1 -KO mice. EP 1 agonist, PGE 2 and capsaicin provoked ATP release from cultured urothelial cells. These results suggest that EP 1 receptor was present in bladder urothelium, and could be activated by PGE 2 to release ATP. EP 1 receptor in urothelium might be important for reflex voiding in pathological conditions.
Urinary prostaglandin E 2 (PGE 2 ) is synthesized locally in the kidney and the urinary bladder (4, 11) . Intravesical administration of PGE 2 in humans causes detrusor overactivity, urgency, and decreased bladder capacity (14) . PGE 2 receptors are classified into four general subtypes based on cloning and pharmacological manipulations (5) : the EP 1 receptor, which mediates Ca ++ mobilization and induces smooth muscle contraction; the EP 2 and EP 4 receptors, which mediate increase in cAMP levels and induce smooth muscle relaxation; and the EP 3 receptor which is an inhibitory receptor that mediates decrease in cAMP levels and inhibits smooth muscle relaxation (13) .
In a previous study, we showed that an EP 1 receptor antagonist, ONO-8711, inhibited bladder afferent nerve activity from inflamed bladder in rat (8) . Intravesical PGE 2 induced detrusor overactivity in rat (9) . Recently, several studies had shown that the release of chemical mediators, such as ATP, from urothelial cells were involved in sensory signaling at the urinary bladder and play a role in the regulation of micturition reflex (6) . Interstitial cystitis altered ATP release from bladder urothelium in cat and man (3, 15) . The urothelium was not only a barrier between the urinary tract and its contents but also a metabolically highly active tissue (2) . A number of studies had shown the presence of a variety of neurotransmitter receptors and ion channels in the urothelium (2) . The localization of afferent nerve fibers next to the urothelium and some fibers ending in the basal layer of the urothelium suggested that urothelial cells possess a signal-transduction mechanism, and that the urothelium plays a role in senso-Mannheim, Germany). The samples, each containing 20 μg of total protein, were electrophoresed by SDS-PAGE (100 V, 1.5 h) on 10% Tris-glycine gels. The proteins were transferred from the gel onto a nitrocellulose membrane. The membranes were incubated overnight with rabbit anti-EP 1 receptor polyclonal antibody (Cayman Chemical, Ann Arbor, USA; 1 : 300 in dilution). This antibody (#106367) was raised against a synthetic peptide from the human EP 1 receptor C-terminal amino acids 380-402 (GLTPSAWEASSLRSSRHSGLSHF). Some membranes were incubated with the EP 1 receptor antibody absorbed with the EP 1 receptor blocking peptide (Cayman Chemical). After washing with 0.1% Triton X100 at room temperature, the membranes were incubated for 40 min with peroxidaselabeled anti-rabbit IgG secondary antibody (Pierce Chemical; 1 : 40,000 in dilution). The blot was exposed to FUJI medical film (FUJIFILM Corporation, Tokyo, Japan) and developed.
Immunohistochemistry. WT mice (n = 5) were anesthetized with 1% halothane (Fluothane ® , Takeda, Chemical Industries Ltd, Japan) and perfused via the aorta with physiological saline, followed by 4% paraformaldehyde in 0.1 M PBS (pH 7.4). The bladder was removed, fixed for 6 h and immersed in 30% sucrose solution before being rapidly frozen in liquid nitrogen. Cryostat sections were cut at 5 µm and incubated overnight at room temperature with rabbit anti-EP 1 receptor antibody (1 : 200). The sections were then incubated at 37°C for 1 h with peroxidase labeled anti-rabbit IgG secondary antibody (1 : 40,000 dilution). For negative control sections, primary antibodies were omitted.
Cell culture. The urothelial layer was detached from the bladder of WT mice by enzymatic digestion (dispase) (Godo Syusei). The layer was further treated with 0.25% trypsin and resuspended in serum-free keratinocyte medium (KURABO, Osaka, Japan). The dissociated cell suspension was plated onto collagen-coated wells at a density of apploximatory 70,000 cells /cm 2 .
ATP measurement. ATP in the culture medium (cultured for 4-5 days) was measured by the luciferinluciferase method with a Luminometer (Kikkoman Co., Ltd., Tokyo, Japan). A 100 μL sample of supernatant was added to a 100 μL reaction mix of luciferin-luciferase (Kikkoman Co., Ltd.). All drugs were incubated for a minimum of 10 min before sample collection. ry functions (2) . Mechanical stress as well as chemical stimuli evoked ATP release from urothelial cells and influenced bladder function (1). We postulated that EP 1 receptor may be present in the urothelium and may be responsible for the release of ATP from the urothelial cells.
It has been reported that PGE 2 increases transient receptor potential vanilloid 1 (TRPV1) activity through EP 1 receptors in mouse dorsal root ganglion (DRG) neurons (12) , and it has been suggested that EP 1 and TRPV1 receptors can functionally interact. We therefore set out to investigate the role of EP 1 receptor in the urinary bladder using EP 1 receptor knockout (EP 1 -KO) mice.
MATERIALS AND METHODS

Animals.
Age-matched male EP 1 -KO mice (10-12 weeks, n = 30) and male WT mice (C57BL/6, 10-12 weeks, n = 60) were used. The EP 1 -KO mice were from Kyoto University. The mouse genes encoding EP 1 receptor was disrupted by gene knockout methods using homologous recombination, as reported previously (16) . C57BL/6 mice, which are the background species of the knockout mice, were used as a control. The mice were housed with free access to food and water and maintained on forced 12 h lightdark cycle at 22-24°C. The protocols for the experiments were previously approved by the Animal Research Committee, Akita University. We followed the APS (American Physiological Society) guideline for animal research. Statistical analysis was performed using Mann-Whitney U and paired t-tests, with p < 0.05 considered significant. All data are presented as means ± SEM.
Western blot. The urinary bladder was excised from deeply anesthetized (intraperitoneal injection of pentobarbital sodium, 35 mg/kg body weight) WT mice (n = 20) and washed in 0.1 M phosphate buffered saline (PBS, pH 7.4). The bladder was weighed and its tissue was incubated for 1 h at 37°C in an essential medium containing 2.5 mg/mL dispase (Godo Syusei, Tokyo Japan), to weaken the association between the urothelial layer and the connective tissue. After incubation, the smooth muscle layers were removed and the stripped mucosa was collected. The urothelial layers and smooth muscle layers were subjected to western blot analysis. The urothelial layers were also examined for cell culture. Whole bladder tissue taken from WT mice (n = 5) was homogenized in lysis buffer (pH 7.4) with protease inhibitor mixture (Roche Diagnostics GmbH, was averaged. After the drug was administered, the parameters were recorded for 30 min; these data were used for evaluation. During continuous cystometrygram, animals were kept at room temperature.
Drugs and vehicle.
The following 4 compounds were tested in WT or EP 1 -KO mice: PGE 2 (1-60 μM), EP 1 receptor agonist (ONO-DI-004, 40 μM), 0.1% acetic acid, and capsaicin (60 μM). PGE 2 (1 mM) and capsaicin (30 mM) were dissolved in absolute ethanol, and stored at −70°C. When used for the CMG experiment, capsaicin with vehicle (VEH, 0.1% ethanol) was infused into the urinary bladder at a concentration of 60 μM. Similarly, PGE 2 was infused at a concentration of 1-60 μM. The PGE 2 and EP 1 receptor agonist (ONO-DI-004) were kindly gifted from Ono Pharmaceutical Co., Ltd (Osaka, Japan).
RESULTS
We assessed both bladder and body weight between WT mice (n = 7) and EP 1 -KO mice (n = 7). There was no significant difference in bladder weight (19.0 ± 0.7 mg and 21.1 ± 1.1 mg, respectively) or in body weight (19.9 ± 0.2 g and 21.0 ± 0.6 g, respectively). We also measured both daily voiding frequency and daily urine volume from WT mice and EP 1 -KO
Surgical procedures and cystometrygram (CMG).
Mice (WT mice, n = 30 and EP 1 -KO mice, n = 30) were anesthetized with 1% halothane (Fluothane ® , Takeda Chemical Industries Ltd, Japan). The abdomen was opened by a lower midline incision, and the urinary bladder was cannulated with polyethylene tubes (PE50). Abdominal incisions were closed with 4-0 nylon sutures. The bladder catheter was connected to a pressure transducer and an infusion pump using a T-connector. The mouse was placed in a Ballman restraining cage (Natsume, Tokyo, Japan). After recovery from anesthesia, room temperature saline was infused into the bladder at a rate of 0.4 mL/h or 0.5 mL/h. Vesical pressue was recorded on an AP601 polygraph (Nihonkoden, Tokyo, Japan) and digitized with a converter for recording on a PowerLab ® system, version 5.0. The parameters used were intercontraction interval (ICI) and maximal voiding pressure (MVP). When the reflex micturition was stabilized, the saline solution was changed to vehicle or drugs. During the course of saline infusion (control condition), three voiding cycles were recorded per animal and each parameter In conscious animals, during continuous infusion (with saline), the ICI in EP 1 -KO mice (624.3 ± 58.5 s, n = 9) was longer than in WT mice (418.4 ± 75.4 s, n = 9, Fig 3. bottom left) . In WT mice, PGE 2 infusion (30 μM) shortened ICI to 47.5% of control (418.4 ± 75.4 s to 198.9 ± 40.3 s, n = 9) (Fig. 3A) . However, the PGE 2 did not alter ICI in EP 1 -KO mice (624.3 ± 58.5 s to 744.9 ± 73.6 s, 119.3% of control, n = 9, Fig. 3B ). PGE 2 did not change the MVP in both mice (Fig. 3, A and B) . In WT mice (n = 5), PGE 2 infusion (1-60 μM) shortened ICI and decreased MVP in a dose-dependent fashion; infusion with PGE 2 shortened ICI and decreased MVP significantly at a concentration of 10 μM (p < 0.05) (Fig. 4A) . In EP 1 -KO mice (n = 5), PGE 2 infusion (1-60 μM) did not change the ICI and MVP significantly (Fig. 4B) . In WT mice, EP 1 agonist shortened ICI from 342.6 ± 27.1 s to 140.4 ± 13.0 s (41% of control, n = 7, Fig. 5A ). However, EP 1 agonist did not alter ICI in EP 1 -KO mice (from 401.1 ± 39.1 s to 408.1 ± 56.8 s, 101% of control, n = 7, Fig. 5B ). EP 1 agonist did not change the MVP in either mouse type (Fig. 5A, B) . mice. There was no significant difference in daily voiding frequency (9 ± 1 times and 8 ± 1 times, respectively, Table 1 ) or in daily urine volume (1.07 ± 0.1 mL and 0.99 ± 0.15 mL, respectively, Table 1 ).
Western blot and immunohistochemistry
The protein samples from the WT mice bladder tissue were shown in Fig. 1 . The urothelial cell layer and whole bladder tissue showed a prominent immunoreactive band at around 68 kilodaltons (kDa). No band of that size was present in the muscle layer. No stained bands were present in the controls after pretreatment with EP 1 receptor blocking peptide (Fig. 1B) .
A strong reaction product for EP 1 receptor was observed in the urothelium. Most urothelial cells showed immunoreactivity for EP 1 receptor in the cytoplasm; the umbrella cells were more intensely stained than basal cells (Fig. 2, A and C) . The smooth muscle showed weak reactions. When the tissue was processed with the same immunostaining protocol only omitting the primary antibody, there was no immunoreactive staining in the urothelium (Fig. 2, B and D) .
CMG in WT and EP 1 -KO mice
In WT mice, 0.1% acetic acid shortened ICI from 298.3 ± 40.2 s to 192.6 ± 32.2 s (64% of control, n = 4, Fig. 6A ). However, 0.1% acetic acid did not alter MVP in WT mice (38.6 ± 5.1 cmH 2 O to 33.8 ± 3.6 cmH 2 O, 87% of control, n = 4, Fig. 6A ). In EP 1 -KO mice, 0.1% acetic acid shortened ICI from 312.1 ± 44.9 s to 198.2 ± 43.9 s (64% of control, n = 4), and decreased MVP from 30.3 ± 2.6 cmH 2 O to 22.5 ± 1.7 cmH 2 O (73% of control, n = 4, Fig. 6B ). In WT mice, capsaicin (60 μM) shortened ICI from 468.2 ± 56.1 s to 228.9 ± 30.9 s (49% of control, n = 5, Fig. 7A ). In EP 1 -KO mice, capsaicin (60 μM) shortened ICI from 686.3 ± 62.9 s to 342.6 ± 62.93 s (50% of control, n = 5, Fig. 7B ). capsaicin did not alter MVP in either mouse type (Fig. 7A, B) .
ATP release from cultured urothelial cells in WT mice
Administration of PGE 2 (1 μM) elicited significant ATP release from urothelial cells (121.7% ± 6.7% of control, p < 0.05, n = 5). EP 1 agonist (1 μM) elicited greater ATP release from the urothelial cells (285.6% ± 30.7% of control, p < 0.05, n = 5). Capsaicin significantly increased the release of ATP from the urothelial cells (227.9% ± 29.1% of control, p < 0.05, n = 5). The ATP release was not evoked by 1% ethanol (VEH, 91.3% ± 8.5% of control, p > 0.05, n = 5).
DISCUSSION
In Western blot analysis, EP 1 receptor was detected as a single band (68 kDa) in the urothelium and the whole bladder tissue, while smooth muscle tissue did not show the same staining pattern. It showed a weak immunoreactive band with a low molecular mass of 54 kDa. We suspect that the 54 kDa band might be a proteolytic cleavage product. From the immunohistochemical study, the EP 1 receptor was strongly detected in the urothelium. Taken together, our results demonstrate that EP 1 receptor was present in the urinary bladder, with a majority being present in the urothelium.
Our study showed that the intravesical administration of PGE 2 or EP 1 agonist had significant effects only on micturition intervals, while the bladder pressure remained unaffected. This data suggested that the EP 1 receptor might be involved in afferent limb for micturition reflex. EP 1 agonist infusion to cultured urothelium cells released ATP. Since ATP from urothelial cells activates P2X3 receptor at primary afferent terminals from the urinary bladder, it is likely that PGE 2 could activate EP 1 receptor at urothelium and release ATP which act on P2X3 receptor at primary afferent terminals. Ikeda et al. indicated that EP 1 receptor antagonist diminished inflammatory neural activities form urinary bladder in rat (8) .
Capsaicin (TRPV1 ligand) facilitated micturition reflex in WT mice. ICI was reduced to 49% of the control. Capsaicin released ATP from the cultured urothelium cells and shorted ICI to 50% of the control in EP 1 -KO mice. It is likely TRPV1-channel at EP 1 -KO mice activated at afferent limb and facilitated micturition reflex. Recently, Moriyama et al. demonstrated EP 1 -antagonist diminished inward current activated by capsaicin at DRG cells (12) . Further experiments must explore to study the interaction of TRPV1 channel and EP 1 receptor in bladder afferent pathway.
Acetic acid infusion to urinary bladder shorted ICI in WT mice. Acetic acid could activate acid sensing ion channel (ASIC) and /or TRPV1 channel (10) . These two channels could activate primary afferent nerve and cause hyper refexia of micturition (7) . However, acetic acid might cause tissue damage tions. REFERENCES and produce inflammation locally. In our study acetic acid shorted ICI in EP 1 -KO mice, suggesting that acetic acid effect was not involved in the PGE 2 -EP 1 receptor.
The ICI in EP 1 -KO mice was longer than in WT mice. However, the daily voiding frequency in WT mice was not significantly different from EP 1 -KO mice. The ICI was recorded after surgery. Thus it could explain that PGE 2 activates EP 1 receptor in WT mice and facilitates micturition reflex. Therefore the ICI in EP 1 -KO mice was longer than in WT mice.
In conclusion, the results of these efforts indicated the EP 1 receptor immunoreactivity was strongly detected in ulothelium. The urothelial EP 1 receptor could be activated by PGE 2 to evoke ATP release from urothelial cells and to facilitate bladder mechanosensitive afferent activity and reflex voiding in mice. The urinary PGE 2 from kidney and bladder may contribute to the bladder overactivity, and affect urinary bladder function in pathological condi- 
